Wells Fargo & Company Haemonetics Corp Transaction History

Wells Fargo & Company

$468 Billion
Q2 2025

A detailed history of Wells Fargo & Company transactions in Haemonetics Corp stock. As of the latest transaction made, Wells Fargo & Company holds 47,073 shares of HAE stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,073

Previous 28,205 66.9%

Holding current value

$2.3 Million

Previous $1.79 Million 95.98%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$56.04 - $74.77 $1.06 Million - $1.41 Million	18,868 Added 66.9%	47,073 $3.51 Million
Q1 2025 May 13, 2025	SELL	$59.34 - $80.05 $574,292 - $774,723	-9,678 Reduced 25.55%	28,205 $1.79 Million
Q4 2024 Feb 12, 2025	SELL	$71.16 - $93.38 $1.22 Million - $1.6 Million	-17,161 Reduced 31.18%	37,883 $2.96 Million
Q3 2024 Nov 13, 2024	SELL	$72.45 - $91.58 $160,404 - $202,758	-2,214 Reduced 3.87%	55,044 $4.42 Million
Q2 2024 Aug 13, 2024	BUY	$81.24 - $97.37 $2.04 Million - $2.45 Million	25,129 Added 78.21%	57,258 $4.74 Million
Q1 2024 May 10, 2024	BUY	$71.24 - $85.35 $17,097 - $20,484	240 Added 0.75%	32,129 $2.74 Million
Q4 2023 Feb 09, 2024	BUY	$80.59 - $92.61 $77,124 - $88,627	957 Added 3.09%	31,889 $2.73 Million
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $815,280 - $923,213	-9,875 Reduced 24.2%	30,932 $2.77 Million
Q2 2023 Aug 15, 2023	BUY	$80.84 - $89.45 $1.09 Million - $1.21 Million	13,507 Added 49.48%	40,807 $3.47 Million
Q1 2023 May 12, 2023	BUY	$72.75 - $90.6 $964,301 - $1.2 Million	13,255 Added 94.38%	27,300 $2.26 Million
Q4 2022 Feb 13, 2023	SELL	$73.85 - $86.14 $135,736 - $158,325	-1,838 Reduced 11.57%	14,045 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $168,567 - $209,471	2,663 Added 20.14%	15,883 $1.18 Million
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $2.46 Million - $3.3 Million	-49,887 Reduced 79.05%	13,220 $862,000
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $119,185 - $172,148	-2,723 Reduced 4.14%	63,107 $3.99 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $15.4 Million - $23.1 Million	-309,991 Reduced 82.48%	65,830 $3.49 Million
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $7.29 Million - $8.93 Million	-126,508 Reduced 25.18%	375,821 $26.5 Million
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $2.5 Million - $5.72 Million	-48,243 Reduced 8.76%	502,329 $33.5 Million
Q1 2021 May 13, 2021	SELL	$111.01 - $139.48 $73.9 Million - $92.8 Million	-665,468 Reduced 54.72%	550,572 $61.1 Million
Q4 2020 Feb 09, 2021	BUY	$88.75 - $119.95 $16 Million - $21.6 Million	180,109 Added 17.39%	1,216,040 $144 Million
Q3 2020 Nov 05, 2020	BUY	$75.65 - $93.58 $13 Million - $16 Million	171,266 Added 19.81%	1,035,931 $90.4 Million
Q2 2020 Aug 13, 2020	BUY	$84.96 - $118.91 $7.35 Million - $10.3 Million	86,522 Added 11.12%	864,665 $77.4 Million
Q1 2020 May 14, 2020	BUY	$74.34 - $121.82 $57.8 Million - $94.8 Million	778,143 New	778,143 $77.6 Million

Others Institutions Holding HAE

# of Institutions

336

Shares Held

53.3M

Call Options Held

540K

Put Options Held

306K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.51B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Haemonetics Corp Transaction History